Anti-SARS-CoV-2 and Autoantibody Profiling of a COVID-19 Patient With Subacute Psychosis Who Remitted After Treatment With Intravenous Immunoglobulin

Affiliations

• ¹ Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
• ² Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
• ³ Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California.
• ⁴ Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Neurology, University of California, San Francisco, California.
• ⁵ Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.
• ⁶ Weill Institute for Neurosciences, University of California, San Francisco, California; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California. Electronic address: chris.bartley@nih.gov.